Atropine Sulfate News
Atropine Sulfate currently has 0 news articles, with 20 predicted indications.
This page combines the AI-predicted indications for Atropine Sulfate with the latest health news. Indications highlighted in orange have recent news coverage.
Drug Information
- Original indication: Ryjunea is indicated for slowing the progression of myopia in paediatric patients. Treatment may be initiated in children aged 3-14 years with a progression rate of 0.5 D or more per year and a...
- Evidence level: L5
- Predicted indications (20):
- migraine disorder (99.6%)
- migraine with brainstem aura (99.4%)
- migraine with or without aura, susceptibility to (98.2%)
- atrophoderma vermiculata (98.2%)
- open-angle glaucoma (98.0%)
- primary hereditary glaucoma (97.8%)
- ulerythema ophryogenesis (97.8%)
- headache disorder (97.2%)
- trigeminal autonomic cephalalgia (96.5%)
- nephrogenic syndrome of inappropriate antidiuresis (96.3%)
- diffuse alopecia areata (95.3%)
- hypertrichosis (disease) (95.3%)
- congenital hypotrichosis milia (95.2%)
- alopecia (95.1%)
- Ambras type hypertrichosis universalis congenita (95.1%)
- common cold (95.1%)
- hypotrichosis simplex of the scalp (95.0%)
- sciatic neuropathy (94.7%)
- malformation syndrome with odontal and/or periodontal component (94.6%)
- syndrome with a Dandy-Walker malformation as major feature (94.6%)
Related News (0)
No related news yet. When news mentions this drug, it will be collected and shown here automatically.
Disclaimer: The news on this page is collected automatically and is for research reference only; it does not constitute medical advice.